The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Drug Testing-Global Market Insights and Sales Trends 2025

Drug Testing-Global Market Insights and Sales Trends 2025

Publishing Date : Mar, 2025

License Type :
 

Report Code : 1823449

No of Pages : 104

Synopsis
Drug testing includes different testing methods which are conducted to detect presence of drugs in the human body. These drugs are tested through blood, sweat, saliva, oral fluid and urine. Drug testing is done mainly for illegal drugs. Illegal drugs are non-prescribed drug which are banned by governments. These drugs are consumed for non-medicinal reasons which can affects mental and physical health of addicts.
The global Drug Testing market size is expected to reach US$ 3430.9 million by 2029, growing at a CAGR of 2.6% from 2023 to 2029. The market is mainly driven by the significant applications of Drug Testing in various end use industries. The expanding demands from the Drug Testing Laboratories, Workplace and Schools, Criminal Justice System & Law Enforcement Agencies and Drug Treatment Centers, are propelling Drug Testing market. Breath Sample, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Urine Sample segment is estimated at % CAGR for the next seven-year period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Drug Testing, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Drug Testing market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Drug Testing market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Drug Testing sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Drug Testing covered in this report include Express Diagnostics, Drgerwerk AG & Co., KGAA Alere, Quest Diagnostics, Laboratory Corporation of America MPD, Shimadzu, Roche Diagnostics, Quest Diagnostics and Thermo Fisher Scientific, etc.
The global Drug Testing market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Express Diagnostics
Drgerwerk AG & Co.
KGAA Alere
Quest Diagnostics
Laboratory Corporation of America MPD
Shimadzu
Roche Diagnostics
Quest Diagnostics
Thermo Fisher Scientific
Siemens Healthcare
Global Drug Testing market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Drug Testing market, Segment by Type:
Breath Sample
Urine Sample
Hair Sample
Oral Fluid
Others
Global Drug Testing market, by Application
Drug Testing Laboratories
Workplace and Schools
Criminal Justice System & Law Enforcement Agencies
Drug Treatment Centers
Hospitals
Pain Management Centers
Personal Users
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Drug Testing companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Index
1 Market Overview of Drug Testing
1.1 Drug Testing Market Overview
1.1.1 Drug Testing Product Scope
1.1.2 Drug Testing Market Status and Outlook
1.2 Global Drug Testing Market Size Overview by Region 2018 VS 2022 VS 2029
1.3 Global Drug Testing Market Size by Region (2018-2029)
1.4 Global Drug Testing Historic Market Size by Region (2018-2023)
1.5 Global Drug Testing Market Size Forecast by Region (2024-2029)
1.6 Key Regions, Drug Testing Market Size (2018-2029)
1.6.1 North America Drug Testing Market Size (2018-2029)
1.6.2 Europe Drug Testing Market Size (2018-2029)
1.6.3 Asia-Pacific Drug Testing Market Size (2018-2029)
1.6.4 Latin America Drug Testing Market Size (2018-2029)
1.6.5 Middle East & Africa Drug Testing Market Size (2018-2029)
2 Drug Testing Market by Type
2.1 Introduction
2.1.1 Breath Sample
2.1.2 Urine Sample
2.1.3 Hair Sample
2.1.4 Oral Fluid
2.1.5 Others
2.2 Global Drug Testing Market Size by Type: 2018 VS 2022 VS 2029
2.2.1 Global Drug Testing Historic Market Size by Type (2018-2023)
2.2.2 Global Drug Testing Forecasted Market Size by Type (2024-2029)
2.3 Key Regions Market Size by Type
2.3.1 North America Drug Testing Revenue Breakdown by Type (2018-2029)
2.3.2 Europe Drug Testing Revenue Breakdown by Type (2018-2029)
2.3.3 Asia-Pacific Drug Testing Revenue Breakdown by Type (2018-2029)
2.3.4 Latin America Drug Testing Revenue Breakdown by Type (2018-2029)
2.3.5 Middle East and Africa Drug Testing Revenue Breakdown by Type (2018-2029)
3 Drug Testing Market Overview by Application
3.1 Introduction
3.1.1 Drug Testing Laboratories
3.1.2 Workplace and Schools
3.1.3 Criminal Justice System & Law Enforcement Agencies
3.1.4 Drug Treatment Centers
3.1.5 Hospitals
3.1.6 Pain Management Centers
3.1.7 Personal Users
3.2 Global Drug Testing Market Size by Application: 2018 VS 2022 VS 2029
3.2.1 Global Drug Testing Historic Market Size by Application (2018-2023)
3.2.2 Global Drug Testing Forecasted Market Size by Application (2024-2029)
3.3 Key Regions Market Size by Application
3.3.1 North America Drug Testing Revenue Breakdown by Application (2018-2029)
3.3.2 Europe Drug Testing Revenue Breakdown by Application (2018-2029)
3.3.3 Asia-Pacific Drug Testing Revenue Breakdown by Application (2018-2029)
3.3.4 Latin America Drug Testing Revenue Breakdown by Application (2018-2029)
3.3.5 Middle East and Africa Drug Testing Revenue Breakdown by Application (2018-2029)
4 Drug Testing Competition Analysis by Players
4.1 Global Drug Testing Market Size by Players (2018-2023)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Drug Testing as of 2022)
4.3 Date of Key Players Enter into Drug Testing Market
4.4 Global Top Players Drug Testing Headquarters and Area Served
4.5 Key Players Drug Testing Product Solution and Service
4.6 Competitive Status
4.6.1 Drug Testing Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 Express Diagnostics
5.1.1 Express Diagnostics Profile
5.1.2 Express Diagnostics Main Business
5.1.3 Express Diagnostics Drug Testing Products, Services and Solutions
5.1.4 Express Diagnostics Drug Testing Revenue (US$ Million) & (2018-2023)
5.1.5 Express Diagnostics Recent Developments
5.2 Drgerwerk AG & Co.
5.2.1 Drgerwerk AG & Co. Profile
5.2.2 Drgerwerk AG & Co. Main Business
5.2.3 Drgerwerk AG & Co. Drug Testing Products, Services and Solutions
5.2.4 Drgerwerk AG & Co. Drug Testing Revenue (US$ Million) & (2018-2023)
5.2.5 Drgerwerk AG & Co. Recent Developments
5.3 KGAA Alere
5.3.1 KGAA Alere Profile
5.3.2 KGAA Alere Main Business
5.3.3 KGAA Alere Drug Testing Products, Services and Solutions
5.3.4 KGAA Alere Drug Testing Revenue (US$ Million) & (2018-2023)
5.3.5 Quest Diagnostics Recent Developments
5.4 Quest Diagnostics
5.4.1 Quest Diagnostics Profile
5.4.2 Quest Diagnostics Main Business
5.4.3 Quest Diagnostics Drug Testing Products, Services and Solutions
5.4.4 Quest Diagnostics Drug Testing Revenue (US$ Million) & (2018-2023)
5.4.5 Quest Diagnostics Recent Developments
5.5 Laboratory Corporation of America MPD
5.5.1 Laboratory Corporation of America MPD Profile
5.5.2 Laboratory Corporation of America MPD Main Business
5.5.3 Laboratory Corporation of America MPD Drug Testing Products, Services and Solutions
5.5.4 Laboratory Corporation of America MPD Drug Testing Revenue (US$ Million) & (2018-2023)
5.5.5 Laboratory Corporation of America MPD Recent Developments
5.6 Shimadzu
5.6.1 Shimadzu Profile
5.6.2 Shimadzu Main Business
5.6.3 Shimadzu Drug Testing Products, Services and Solutions
5.6.4 Shimadzu Drug Testing Revenue (US$ Million) & (2018-2023)
5.6.5 Shimadzu Recent Developments
5.7 Roche Diagnostics
5.7.1 Roche Diagnostics Profile
5.7.2 Roche Diagnostics Main Business
5.7.3 Roche Diagnostics Drug Testing Products, Services and Solutions
5.7.4 Roche Diagnostics Drug Testing Revenue (US$ Million) & (2018-2023)
5.7.5 Roche Diagnostics Recent Developments
5.8 Quest Diagnostics
5.8.1 Quest Diagnostics Profile
5.8.2 Quest Diagnostics Main Business
5.8.3 Quest Diagnostics Drug Testing Products, Services and Solutions
5.8.4 Quest Diagnostics Drug Testing Revenue (US$ Million) & (2018-2023)
5.8.5 Quest Diagnostics Recent Developments
5.9 Thermo Fisher Scientific
5.9.1 Thermo Fisher Scientific Profile
5.9.2 Thermo Fisher Scientific Main Business
5.9.3 Thermo Fisher Scientific Drug Testing Products, Services and Solutions
5.9.4 Thermo Fisher Scientific Drug Testing Revenue (US$ Million) & (2018-2023)
5.9.5 Thermo Fisher Scientific Recent Developments
5.10 Siemens Healthcare
5.10.1 Siemens Healthcare Profile
5.10.2 Siemens Healthcare Main Business
5.10.3 Siemens Healthcare Drug Testing Products, Services and Solutions
5.10.4 Siemens Healthcare Drug Testing Revenue (US$ Million) & (2018-2023)
5.10.5 Siemens Healthcare Recent Developments
6 North America
6.1 North America Drug Testing Market Size by Country (2018-2029)
6.2 U.S.
6.3 Canada
7 Europe
7.1 Europe Drug Testing Market Size by Country (2018-2029)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Drug Testing Market Size by Region (2018-2029)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Drug Testing Market Size by Country (2018-2029)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Drug Testing Market Size by Country (2018-2029)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Drug Testing Market Dynamics
11.1 Drug Testing Industry Trends
11.2 Drug Testing Market Drivers
11.3 Drug Testing Market Challenges
11.4 Drug Testing Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List

Published By : QY Research

Why ‘The Market Reports’